William Guyer, Chief Development Officer at CORCEPT THERAPEUTICS INC (CORT), sold 20,000 shares at $70.60 ($1.4M) on 2026-06-02, disclosed to the SEC on 2026-06-04.
Scheduled sale ($1.4M) by Chief Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CORT | SELL | 2026-05-07 | $1.0M | — | Filing → |
| CORT | SELL | 2026-04-08 | $819K | — | Filing → |
| CORT | SELL | 2026-03-24 | $424K | — | Filing → |